START

Running trials

• Recruiting

  Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

  NCT07288359· Phase 1/2· Source

• Recruiting

  Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  NCT06993844· Phase 1/2· Source

• Recruiting

  Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  NCT06040541· Phase 1· Source

• Active, not recruiting

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cervical cancer1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting

Researchers

No researcher is linked here yet.